. Author manuscript; available in PMC: 2022 Jun 1.

Published in final edited form as: J Vasc Surg. 2020 Dec 2;73(6):2021–2029. doi: 10.1016/j.jvs.2020.11.031

Table II:

Unadjusted in-hospital outcomes after transfemoral carotid artery stenting stratified by specific pre-procedural symptom status

	1. Stroke	2. Hemispheric TIA	P-value 1 vs. 2	3. Ocular TIA	P-value 3 vs. 1	P-value 3 vs. 2	P-value 1 vs. 2 vs. 3	4. Asymptomatic	P-value 4 vs. 2	P-value 4 vs. 3
In-hospital outcomes	1. Stroke	2. Hemispheric TIA	P-value 1 vs. 2	3. Ocular TIA	P-value 3 vs. 1	P-value 3 vs. 2	P-value 1 vs. 2 vs. 3	4. Asymptomatic	P-value 4 vs. 2	P-value 4 vs. 3
N	2650	842		360				5160
Stroke or death	145 (5.5)	20 (2.4)	<.001	10 (2.8)	.03	.68	<.001	73 (1.4)	.04	.04
Stroke	95 (3.6)	15 (1.8)	.009	9 (2.5)	.29	.42	.02	54 (1.0)	.06	.01
Mortality	68 (2.6)	6 (0.7)	.001	2 (0.6)	.02	.76	<.001	21 (0.4)	.22	.67
MI	25 (0. 9)	5 (0.6)	.34	2 (0.6)	.46	.94	.52	21 (0.4)	.44	.67
LOS > 2 days	1066 (40.2)	173 (20.5)	<.001	40 (11.1)	<.001	<.001	<.001	580 (11.2)	<.001	.94

TIA, transient ischemic attack; MI, myocardial infarction; LOS, hospital length of stay. Values are presented as numbers (%).